中信建投：立足于内，开拓于外，中国医药行业需加速国际化布局

Core Viewpoint - The Chinese pharmaceutical industry needs to "focus on domestic stability while expanding internationally" in the context of a reshaped global landscape, promoting technological self-sufficiency and accelerating internationalization to address tariff policies and geopolitical challenges, while seizing opportunities from global pharmaceutical industry chain transformations [1] Summary by Relevant Categories Industry Outlook - The industry is expected to benefit from the trend of self-sufficiency and the export of medical devices, with a long-term positive outlook [1] - There is an emphasis on stabilizing domestic foundations while actively participating in industry consolidation and exploring overseas markets [1] Tariff and Geopolitical Impact - The recent U.S. tariff increases on China included a temporary exemption for pharmaceuticals, indicating limited impact on the sector [1] - The primary method for innovative drug companies to expand internationally is through intellectual property (IP) transfer, which also has a limited effect [1]